WHO this week announced a project to speed development of a messenger RNA vaccine against highly pathogenic avian influenza in humans. “This initiative exemplifies why WHO established the mRNA Technology Transfer Programme (TTP) — to foster greater research, development and production in low- ...
"There is an opportunity to strengthen partnerships to transfer vaccine manufacturing technology, whether between the developed countries and the six countries, or among the six countries themselves," she said, stressing that the WHO will play a fundamental role in supporting the pharmaceutical industrie...
In late July, the World Health Organization (WHO)announcedplans to develop a messenger RNA (mRNA) vaccine to protect people in low- and middle-income countries from the highly pathogenic avian influenza A(H5N1) virus. The initiative comes during continued concern about a public health ris...
Who made the mRNA vaccine? Measuring division of labor in therapeutic innovationTo accelerate future vaccine development, understanding the longer-term funding dynamics behind recent successes such as the USA's Operation Warp Speed and the UK's Vaccine Taskforce is imperative....
The World Health Organization launched an initiative on Monday to help accelerate the development of a human bird flu vaccine using mRNA technology.
公共卫生投资的增加:预计全球将增加对公共卫生基础设施的投资,包括疫苗接种计划,以提高对未来疫情的准备和应对能力。 参考链接:https://www.who.int/publications/m/item/global-vaccine-market-report-2023 生物制品微信群! 请注明:姓名+研究方向! 版 权 声 明...
参考链接:https://www.who.int/publications/m/item/global-vaccine-market-report-2023 识别微信二维码,添加生物制品圈小编,符合条件者即可加入 生物制品微信群! 请注明:姓名+研究方向! 版 权 声 明 本公众号所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,...
Joel Kallman, the 54-year-old Oracle APEX software developer who designed the CDC vaccine tracking system, is dead two months after the first experimental mRNA shot. Jovita Moore, an Atlanta news anchor, developed two brain tumors 12 days after second experimental...
At a press briefing in Geneva on Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus said the new hub will be in South Korea and will share mRNA technology being developed by WHO and partners in South Africa, where scientists are working to recreate the COVID-19 vaccine made by Modern...
• If you had a severe or immediate allergic reaction after getting the first dose of an mRNA COVID-19 vaccine, you should not get a second dose of either of the mRNA COVID-19 vaccines (Moderna or Pfizer-BioNTech). Who developed the Moderna COVID-19 vaccine?